News – Page 884 – Endpoints News

Wave spotlights ‘positive’ data on Huntington’s drug, but stock takes a beating as Roche, Ionis rival stays in ...

6 years ago

Chinese court sentences Jiankui He to 3 years in jail — and confirms birth of 3rd CRISPR baby

6 years ago

Antibiotics apocalypse: Melinta files for bankruptcy protection as a plague of woes afflicts the field

6 years ago

Banking on Shanghai's biotech boom, this Eli Lilly-backed player grabs $100M to push next-gen I/O therapies

6 years ago

On a spree, Astellas bags a next-gen, Parker-backed CAR-T platform with $665M buyout deal

6 years ago

Biotech takes a Christmas beating after safety fears force researchers to halt all hep B studies

6 years ago

Spectrum shares crater as first round of pivotal data for their TKI falls short of primary endpoint

6 years ago

The top 10 most popular Endpoints News pieces of 2019 — going viral is a whole new game in biopharma now

6 years ago

FDA makes it official, once again rejecting battered Correvio’s heart drug

6 years ago

Sanofi's hurried, $2.5B pursuit for Synthorx drove buyout price high and left keen rival sorely disappointed

6 years ago

Gilead gets ball rolling on JAKs game in Japan

6 years ago

As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis

6 years ago

Allergan gets a win: FDA approves ubrogepant as cascade of treatments reshape migraine field

6 years ago

Intra-Cellular's checkered developmental path ends in schizophrenia approval, shares skyrocket

6 years ago

Over a decade into the milestone boom, it's time to ask. Just how often do they really pay off?

6 years ago

Pfizer inks a back-ended $250M deal for skin-targeted JAK, pays $25M to set up the next leg of their hemophilia A R&D ...

6 years ago

J&J rounds out the year with twin buyouts, gaining control of delivery and surgical robotics tech

6 years ago

Cirius withdraws $86M IPO as vaunted 'Year of NASH' draws to brutal close

6 years ago

FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues

6 years ago

Sarepta cements its DMD throne with $1B+ gene therapy deal with mighty Roche

6 years ago

EMA loses more than 100 staffers in move to Amsterdam

6 years ago

Eisai scores an FDA approval for a homegrown sleep drug

6 years ago

Why wait? The FDA stamps an ultra-fast OK on a HER2+ drug expected to create AstraZeneca's next blockbuster franchise

6 years ago

Bill Lundberg takes over the reins at Merus; Former Akcea COO Jeffrey Goldberg takes the helm of Immunitas

6 years ago

First page Previous page 881 882 883884885 886 887 Next page Last page